A research study to look at how CagriSema influences food intake, appetite and emptying of the stomach in people with excess body weight
NN9838-4695
Phase 1 other active
Quick answer
A research study to look at how CagriSema influences food intake, appetite and emptying of the stomach in people with excess body weight for Obesity is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Obesity
- Phase
- Phase 1
- Modality
- other
- Status
- active